Correlation Between Regen BioPharma and Codiak BioSciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Codiak BioSciences, you can compare the effects of market volatilities on Regen BioPharma and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Codiak BioSciences.

Diversification Opportunities for Regen BioPharma and Codiak BioSciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regen and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Codiak BioSciences go up and down completely randomly.

Pair Corralation between Regen BioPharma and Codiak BioSciences

If you would invest (100.00) in Codiak BioSciences on September 2, 2024 and sell it today you would earn a total of  100.00  from holding Codiak BioSciences or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Regen BioPharma  vs.  Codiak BioSciences

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Codiak BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Codiak BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking signals, Codiak BioSciences is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Regen BioPharma and Codiak BioSciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Codiak BioSciences

The main advantage of trading using opposite Regen BioPharma and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.
The idea behind Regen BioPharma and Codiak BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments